Michael Bookman

IMRX

Michael Bookman serves as CHIEF LEGAL OFFICER, SECRETARY at Immuneering Corporation (IMRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$32.9K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$32.9K

Companies Traded

IMRX

Active Period

Aug 2021 – Oct 2025

3 total trades

Most Recent

Buy IMRX

Oct 1, 2025 · $7.0K

Michael Bookman's Insider Trading at Immuneering Corporation (IMRX)

Buys

3 · $32.9K

Sells

0 · $0.00

Total Shares Bought

3,422

Total Shares Sold

IMRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 1, 2025	Buy	1,020	$6.83	$7.0K	0
May 18, 2022	Buy	1,000	$4.88	$4.9K	2,402
Aug 4, 2021	Buy	1,402	$15.00	$21.0K	1,402

Related Insiders

Thomas J. Schall

Director

IMRXBuy · Jan 20, 2026

Harold Eugene Brakewood

Chief Business Officer

IMRXBuy · Jan 16, 2026

Leah R Neufeld

officer: CHIEF PEOPLE OFFICER

IMRXBuy · Jan 15, 2026

Brett Matthew Hall

CHIEF SCIENTIFIC OFFICER

IMRXBuy · Jan 15, 2026

Peter Feinberg

Director

IMRXBuy · Jan 14, 2026

Mallory Morales

Chief Accounting Officer

IMRXBuy · Oct 1, 2025

HAUSMAN DIANA

Director

IMRXBuy · Jul 2, 2025

Benjamin J. Zeskind

PRESIDENT AND CEO

IMRXBuy · Jul 1, 2025

Explore More Insider Trading Data

IMRX Insider Trading Activity

View all insider trades at Immuneering Corporation

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity